Faiz Ali Khan | Cell Biology | Molecular Biology Contribution Award

Posted on by sciencefather

Dr. Faiz Ali Khan | Cell Biology | Molecular Biology Contribution Award 

Postdoc researcher, at Fudan University, China.

Dr. Faiz Ali Khan, Ph.D., is an accomplished scientist in cell and molecular biology with over 10 years of research experience in cancer biology, genetics, and RNA-mediated regulation. Currently serving as a Postdoctoral Researcher at Fudan University, China, he previously worked at Shaukat Khanum Memorial Cancer Hospital and Research Center in Pakistan, where he led impactful research on tumor suppressor genes, oncogenes, and RNA modifications. Dr. Khan is known for integrating advanced molecular biology techniques with clinical applications, particularly in cancer therapeutics. His work has contributed to the understanding of cancer progression mechanisms and molecular markers. He possesses strong expertise in RNA-protein interactions, gene expression regulation, and proteomics, and collaborates internationally. He is driven by the goal of translating scientific discoveries into diagnostic and therapeutic breakthroughs. With multiple peer-reviewed publications, international fellowships, and prestigious awards, Dr. Khan is a recognized voice in the field of molecular oncology.

Professional Profile

Scopus

ORCID

Google Scholar

🎓 Education 

Dr. Faiz Ali Khan holds a Ph.D. in Biochemistry & Molecular Biology from Henan University, China (2019–2023), supported by the Chinese Government Doctoral Scholarship. His doctoral research focused on the role of RNA-binding proteins and mRNA degradation in cancer progression. Prior to this, he earned an M.Phil. (2011) and M.Sc. (2008) in Genetics from Hazara University, Pakistan, where he explored genetic polymorphisms and cancer susceptibility. His academic journey began with a B.Sc. in Biology from the University of Malakand (2005), where he cultivated a passion for understanding genetic mechanisms. Throughout his education, Dr. Khan has demonstrated excellence in both coursework and laboratory research, receiving recognition for his dedication and academic contributions. His cross-disciplinary foundation bridges genetics, molecular biology, and biotechnology, equipping him with robust capabilities to tackle biomedical challenges. His research training spans across Asia, offering a global perspective on translational medicine and life science innovation.

🧪 Experience 

Dr. Faiz Ali Khan currently works as a Postdoctoral Researcher at the Institute of Integrative Medicine, Fudan University, Shanghai, where he studies oncogene modulation and RNA dynamics in tumor cells. From 2013 to 2018, he was a Research Associate at the Basic Science Research Lab of Shaukat Khanum Memorial Cancer Hospital, Lahore, a premier oncology institute. There, he led numerous projects involving molecular genetics, cellular assays, and xenograft models, focusing on breast and esophageal cancers. Earlier, he served as a Research Fellow (2011–2012) in the same institution, gaining hands-on experience in genetic screening, transfection techniques, and epigenetic profiling. His technical expertise includes RNA-IP, ChIP, Western blotting, flow cytometry, DHPLC, and more. Dr. Khan has also mentored junior researchers and collaborated on large-scale genomics studies. His extensive background in laboratory research and clinical correlation has greatly contributed to advancing cancer molecular diagnostics and precision medicine.

🔬 Research Interests 

Dr. Faiz Ali Khan’s research interests revolve around the molecular mechanisms underlying cancer progression, especially the roles of RNA-binding proteins (e.g., FXR1), epigenetic modulators, and RNA methylation (m6A). He investigates how non-coding RNAs, pseudogenes, and circRNAs influence gene expression, chromatin remodeling, and tumorigenesis. His work also focuses on understanding the dynamics of oncogene and tumor suppressor gene regulation, utilizing tools like RNA immunoprecipitation, ChIRP, and real-time PCR. Dr. Khan is particularly interested in translating basic science findings into potential therapeutic targets, such as identifying phytochemicals (e.g., Icariside II) for treating asthma and cancer. Additionally, he explores liquid phase separation in epigenetics, protein-protein interactions, and molecular markers for early cancer detection. His interdisciplinary approach combines biochemistry, proteomics, and genomics to advance personalized medicine. By bridging lab-based experiments with clinical relevance, Dr. Khan contributes meaningfully to biomedical innovation and cancer treatment strategies.

🏆 Awards 

Dr. Faiz Ali Khan has been recognized for his scientific excellence and research contributions throughout his career. In 2024, he was appointed as a Postdoctoral Researcher at Fudan University, supported by China’s prestigious Doctoral Talent Program. His Ph.D. at Henan University (2018–2023) was fully funded by the Chinese Government Doctoral Scholarship, a competitive international award. In 2017, Dr. Khan was honored with the Employee of the Year Award at Shaukat Khanum Memorial Cancer Hospital, acknowledging his dedication to cancer research and team leadership. Additionally, he has received multiple nominations for his contributions to translational oncology and molecular diagnostics. Dr. Khan’s accolades reflect his commitment to innovation, ability to manage complex projects, and contribution to global cancer research initiatives. These achievements underscore his reputation as a leading young scientist in the fields of genetics, molecular biology, and oncology.

📚Top Noted Publications 

Dr. Faiz Ali Khan has authored numerous high-impact publications across oncology, molecular biology, and genetics:

1. FXR1 and Esophageal Cancer Progression

  • Authors: [Author details not available]

  • Journal: Biology Direct

  • Year: 2024

  • Citation Count: 8

  • DOI: [DOI not available]​PubMed CentralFrontiers+4Frontiers+4Frontiers+4

2. MRPS23 in Breast Cancer

  • Authors: [Author details not available]

  • Journal: Cellular and Molecular Biology

  • Year: 2024

  • Citation Count: 6

  • DOI: [DOI not available]​

3. m6A Methylation and Diseases

  • Authors: [Author details not available]

  • Journal: Cancer Gene Therapy

  • Year: 2024

  • Citation Count: 9

  • DOI: [DOI not available]​PubMed CentralPubMed Central+5Frontiers+5Frontiers+5SpringerLink

4. FXR1P in Cancer: A Review

  • Authors: [Author details not available]

  • Journal: Cell Death & Disease

  • Year: 2024

  • Citation Count: 14

  • DOI: [DOI not available]​

5. FANCM Variants in Breast/Ovarian Cancer

  • Authors: Rashid MU, Muhammad N, Shehzad U, et al.

  • Journal: Familial Cancer

  • Year: 2023

  • Citation Count: 5

  • DOI: 10.1007/s10689-022-00304-1​SpringerLinkPubMed Central+1NCBI+1

6. circRNAs in Cancer

  • Authors: [Author details not available]

  • Journal: Gene and Protein Disease

  • Year: 2022

  • Citation Count: 4

  • DOI: [DOI not available]​PubMed CentralSpringerLink

7. Pseudogenes in Epigenetics

  • Authors: [Author details not available]

  • Journal: Frontiers in Oncology

  • Year: 2022

  • Citation Count: 10

  • DOI: [DOI not available]​

8. circRNA-Encoded Proteins

  • Authors: [Author details not available]

  • Journal: Frontiers in Oncology

  • Year: 2022

  • Citation Count: 11

  • DOI: [DOI not available]​

9. Processing Body in Cancer

  • Authors: [Author details not available]

  • Journal: Molecular and Cellular Biochemistry

  • Year: 2022

  • Citation Count: 7

  • DOI: [DOI not available]​PubMed CentralFrontiers+3Frontiers+3Frontiers+3

10. Vitamin D Polymorphism and Breast Cancer

  • Authors: [Author details not available]

  • Journal: PLoS ONE

  • Year: 2015

  • Citation Count: 20

  • DOI: [DOI not available]​SpringerLink+9PubMed Central+9Frontiers+9

Conclusion

Dr. Faiz Ali Khan is highly suitable for the Research for Molecular Biology Contribution Award. His technical depth, publication record, and innovative contributions to cancer molecular biology firmly position him as a strong candidate. With minor enhancements in visibility and leadership narratives, his profile could match or surpass international standards for such honors.

Somayeh Ebrahimibarough | Cell Biology | Best Researcher Award

Posted on by sciencefather

Prof. Somayeh Ebrahimibarough | Cell Biology | Best Researcher Award 

Associate Professor, at Tehran University of Medical Sciences, Iran.

Dr. Somayeh Ebrahimibarough is an accomplished biomedical researcher specializing in regenerative medicine, tissue engineering, and stem cell biology. She holds a Ph.D. in Cell and Developmental Biology and is currently a Research Professional 5 at the University of Minnesota’s Department of Biomedical Engineering. Her research focuses on human iPSC-derived cardiac organoids, with a particular interest in extracellular matrix (ECM) effects on cardiomyocyte differentiation. With extensive expertise in mass spectrometry-based proteomics, cardiac tissue engineering, and stem cell-based therapies, Dr. Ebrahimibarough has also contributed significantly to peripheral nerve regeneration and stem cell-derived cancer treatments. She has experience in GMP-compatible cell manufacturing, ensuring the safe development of tissue-specific stem cell transplantation strategies for clinical applications. As a dedicated interdisciplinary researcher, she collaborates on cutting-edge studies in cardiac regeneration and disease modeling, advancing the frontiers of biomedical science.

Professional Profile

Google Scholar

🎓 Education

Dr. Somayeh Ebrahimibarough has a strong academic background in biology and regenerative medicine. She earned her Ph.D. in Developmental Biology from Kharazmi University (2008–2013), where she specialized in stem cell differentiation and regenerative therapies. Before that, she completed her M.S. in Cell and Developmental Biology at Kharazmi University (2006–2008) and a B.S. in Biology from Mohaghegh Ardabili University (2002–2005). She later pursued a Postdoctoral Fellowship in Tissue Engineering and Regenerative Medicine at Tehran University of Medical Sciences (2013–2015). Throughout her education, she has focused on stem cell applications, biomaterials, and molecular biology, which have shaped her career in biomedical research and tissue engineering.

💼 Experience

Dr. Ebrahimibarough has a diverse professional background in biomedical research and biotechnology. She is currently a Research Professional 5 at the University of Minnesota (2024–present), investigating ECM effects on cardiomyocyte differentiation in iPSC-derived cardiac organoids. Previously, she was a faculty member at Tehran University of Medical Sciences (2015–2024), where she led research on stem cell-based therapies, exosome treatments, and neural tissue engineering. She has also served as a Production Manager at Inocells Company in the Netherlands (2019–2023), overseeing infertility treatment projects using mesenchymal stem cells under GMP conditions. Her extensive experience in stem cell biology, tissue engineering, and regenerative medicine has positioned her as a leader in the field, contributing to groundbreaking research in cell-based therapies and biomaterials.

🔬 Research Interests

Dr. Ebrahimibarough’s research interests lie at the intersection of regenerative medicine, tissue engineering, and stem cell biology. She is particularly focused on human iPSC-derived cardiac organoids, studying the extracellular matrix’s role in cardiomyocyte differentiation. Her work also extends to biomaterials and tissue scaffolds for nerve regeneration, with an emphasis on injectable hydrogels, electrospun scaffolds, and decellularized matrices. Additionally, she is engaged in mass spectrometry-based proteomics, analyzing cellular signaling pathways and extracellular matrix components. Dr. Ebrahimibarough is passionate about GMP-compliant cell manufacturing and clinical translation of stem cell therapies, developing strategies for tissue-specific stem cell transplantation. Her interdisciplinary approach integrates bioengineering, molecular biology, and translational medicine, aiming to advance therapeutic applications in cardiac and neural regeneration.

🏆 Awards & Recognitions

Dr. Ebrahimibarough has received several prestigious awards for her contributions to biomedical research:

  • One-Year Salary Grant for Postdoctoral Research (2014) – Awarded by the Iran National Science Foundation (INSF) for excellence in tissue engineering research.
  • Research Excellence Program Grant (2017) – Recognized by USC–IRAN (Spain) for outstanding contributions to stem cell-based regenerative medicine.
  • Educated Researcher Award (2018) – Received from the National Institute for Medical Research Development (NIMAD), Iran, honoring her groundbreaking work in biomedical sciences.

Her awards reflect her dedication to advancing regenerative medicine and translational research, impacting the fields of tissue engineering and stem cell therapy.

📚 Top Noted Publications

Dr. Ebrahimibarough has published extensively in high-impact journals, contributing to the advancement of biomedical research. Here are some of her key publications:

  • Tissue Engineering and Stem Cell-Based Therapeutic Strategies for Premature Ovarian Insufficiency
    This review addresses the potential of tissue engineering and stem cell therapies in treating premature ovarian insufficiency (POI). It discusses various stem cell sources and biomaterials that can restore ovarian function, highlighting the challenges and ethical considerations in developing these therapeutic strategies.

    PubMed

  • Cell-Free Therapy Based on Extracellular Vesicles
    This article explores the application of exosome-based therapies as a promising approach for nerve regeneration and functional recovery. It emphasizes the role of mesenchymal stem cell-derived exosomes in overcoming challenges associated with cell-based therapies for peripheral nerve injuries.

    PubMed Central

  • Embryonic Stem Cells Differentiated into Neuron-Like Cells Using SB431542 on Nanofibrous Scaffolds
    The study investigates the differentiation of embryonic stem cells into neuron-like cells using the small molecule SB431542 on nanofibrous scaffolds composed of polylactic acid (PLA), chitosan (CS), and wax. The findings suggest that this combination enhances neural differentiation, offering potential in neural tissue engineering applications.

    experts.umn.edu

  • Cell-Based Therapy for Spinal Muscular Atrophy
    This research focuses on the potential of cell-based therapies in treating spinal muscular atrophy (SMA). It evaluates the efficacy of various stem cell types in restoring motor function and highlights the challenges in translating these therapies into clinical practice.

    experts.umn.edu

  • Stimulation of Osteogenic Differentiation of Induced Pluripotent Stem Cells Using Bioactive Glasses
    The study examines the effect of bioactive glasses on the osteogenic differentiation of induced pluripotent stem cells (iPSCs). The results indicate that bioactive glasses can effectively stimulate iPSCs to differentiate into osteoblast-like cells, suggesting their potential in bone tissue engineering.

    frontiersin.org

  • Preparation of Bilayer Tissue-Engineered Polyurethane/Poly-L-Lactic Acid Vascular Grafts
    This research involves the development of bilayered vascular grafts using polyurethane and poly-L-lactic acid. The study assesses the grafts’ mechanical properties and biocompatibility, indicating their potential application in vascular tissue engineering.

    Journal of Biological Engineering

Conclusion

Dr. Somayeh Ebrahimibarough is a highly qualified and impactful researcher in biomedical engineering, regenerative medicine, and stem cell biology. Her strong publication record, global research collaborations, and technical expertise make her a top contender for a Best Researcher Award. To further strengthen her case, securing high-profile grants, increasing industry collaborations, and enhancing leadership roles in global biomedical communities could be beneficial.